Pancreatic Cancer 2018: Surgical and Medical Treatment
Presented by Timothy R Donahue, MD & Zev Wainberg, MD
About the Lecture
Pancreatic cancer is the fourth most common cause of cancer-related deaths in the United States. It is the second most common cause of gastrointestinal cancers, behind colon cancer. Patients often do not experience symptoms until the cancer involves the surrounding blood vessels or spreads beyond the pancreas, and they are initially treated with chemotherapy and occasionally radiation therapy. Surgical treatment is offered to patients with early-stage tumors that are confined to the region of the pancreas; it includes a Whipple resection, which is a complex surgery. This lecture will address the surgical and medical treatment of patients with both early and late-stage disease. Up to date information on improved survival associated with chemotherapy regimens and biologic agents will be reviewed. We will also highlight the diverse resources that are available at the UCLA Center for Pancreatic Diseases, including clinical trials, palliative treatments, support services, etc.
About the Speakers
Timothy R. Donahue, MD is Chief of Gastrointestinal and Pancreatic Surgery, and an Associate Professor of Surgery at the David Geffen School of Medicine at UCLA. He has a joint appointment in the Department of Molecular and Medical Pharmacology to facilitate his research program. Dr. Donahue is the Director of the General Surgery Residency Program. His clinical practice focuses on pancreatic surgery, and his research program examines the molecular genetics of pancreatic cancer.
Zev Wainberg, MD is an Assistant Professor in the Department of Medicine, Division of Hematology/Oncology at the David Geffen School of Medicine UCLA. He is the Co-director of the UCLA Gastro-Intestinal Oncology Program and the medical director of the UCLA Colorectal Cancer Center. Dr. Wainberg has an active practice and has many clinical trials devoted to these diseases. His research involves a variety of clinical trials in multiple gastrointestinal cancers including pancreas, colon, gastric and esophageal. Dr. Wainberg’s laboratory-based research efforts involve the testing of novel therapeutics against all gastrointestinal cancers.